ALPHA (0303) - Total Liabilities
Based on the latest financial reports, ALPHA (0303) has total liabilities worth RM58.34 Million MYR (≈ $14.65 Million USD) as of November 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset growth rate of ALPHA to track the company's year-over-year net asset growth rate.
ALPHA - Total Liabilities Trend (2020–2025)
This chart illustrates how ALPHA's total liabilities have evolved over time, based on quarterly financial data. See ALPHA (0303) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
ALPHA Competitors by Total Liabilities
The table below lists competitors of ALPHA ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
FM Mattsson Mora Group AB (publ)
ST:FMM-B
|
Sweden | Skr804.50 Million |
|
Shandong Longda Meat Foodstuff Co Ltd
SHE:002726
|
China | CN¥3.85 Billion |
|
Keros Therapeutics Inc
NASDAQ:KROS
|
USA | $39.20 Million |
|
Jumbo Interactive Ltd
AU:JIN
|
Australia | AU$234.44 Million |
|
Marie Brizard Wine & Spirits
PA:MBWS
|
France | €65.04 Million |
|
Know Labs Inc.
NYSE MKT:KNW
|
USA | $5.28 Million |
|
Eaton Vance Senior Floating Rate Closed Fund
NYSE:EFR
|
USA | $130.48 Million |
Liability Composition Analysis (2020–2025)
This chart breaks down ALPHA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see ALPHA market cap and net worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 5.63 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.30 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.22 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how ALPHA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for ALPHA (2020–2025)
The table below shows the annual total liabilities of ALPHA from 2020 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-05-31 | RM46.66 Million ≈ $11.71 Million |
+21.23% |
| 2024-05-31 | RM38.49 Million ≈ $9.66 Million |
-6.81% |
| 2023-05-31 | RM41.30 Million ≈ $10.37 Million |
-14.16% |
| 2022-05-31 | RM48.11 Million ≈ $12.08 Million |
+10.19% |
| 2021-05-31 | RM43.66 Million ≈ $10.96 Million |
-6.31% |
| 2020-05-31 | RM46.61 Million ≈ $11.70 Million |
-- |
About ALPHA
Alpha IVF Group Berhad, together with its subsidiaries, operates as a fertility care specialist that focuses on the provision of assisted reproductive services in Malaysia, Singapore, Indonesia, China, Middle East, the Philippines, and internationally. The company offers assisted reproductive treatment services comprising ovulation induction, intra-uterine insemination, in-vitro fertilization tre… Read more